We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$5.13M
2
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$3.96M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$3.79M
4
PTC icon
PTC
PTC
+$3.74M
5
KSU
Kansas City Southern
KSU
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 10.82%
3 Consumer Discretionary 10.62%
4 Healthcare 9.9%
5 Industrials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FPI
2576
Farmland Partners
FPI
$432M
$26K ﹤0.01%
2,123
-675
-24% -$8.68K
GEF.B icon
2577
Greif Class B
GEF.B
$4.18B
$26K ﹤0.01%
446
– –
IPI icon
2578
Intrepid Potash
IPI
$492M
$26K ﹤0.01%
831
– –
LFCR icon
2579
Lifecore Biomedical
LFCR
$175M
$26K ﹤0.01%
2,282
– –
NCMI icon
2580
National CineMedia
NCMI
$260M
$26K ﹤0.01%
523
– –
NNBR icon
2581
NN Inc
NNBR
$323M
$26K ﹤0.01%
3,488
– –
NUVB icon
2582
Nuvation Bio
NUVB
$2.13B
$26K ﹤0.01%
+2,777
New +$31.7K
SMBK icon
2583
SmartFinancial
SMBK
$899M
$26K ﹤0.01%
1,098
– –
SYRE icon
2584
Spyre Therapeutics
SYRE
$9.04B
$26K ﹤0.01%
148
– –
TIL icon
2585
Instil Bio
TIL
$49.9M
$26K ﹤0.01%
+68
New +$25.2K
KNTE
2586
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$26K ﹤0.01%
1,099
– –
CSTR
2587
DELISTED
CapStar Financial Holdings, Inc
CSTR
$26K ﹤0.01%
1,274
– –
CBAY
2588
DELISTED
Cymabay Therapeutics
CBAY
$26K ﹤0.01%
5,958
– –
CURO
2589
DELISTED
CURO Group Holdings Corp.
CURO
$26K ﹤0.01%
1,544
– –
LTRPA
2590
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$26K ﹤0.01%
6,271
– –
SQZ
2591
DELISTED
SQZ Biotechnologies Company
SQZ
$26K ﹤0.01%
1,785
+1,412
+379% +$18.4K
MILE
2592
DELISTED
Metromile, Inc. Common Stock
MILE
$26K ﹤0.01%
+2,879
New +$25.8K
EMKR
2593
DELISTED
Emcore Corp
EMKR
$26K ﹤0.01%
+286
New +$23.1K
YELL
2594
DELISTED
Yellow Corporation Common Stock
YELL
$26K ﹤0.01%
+3,948
New +$29.4K
BDSI
2595
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$26K ﹤0.01%
7,195
– –
ALT icon
2596
Altimmune
ALT
$566M
$25K ﹤0.01%
+2,548
New +$34.8K
APLT
2597
DELISTED
Applied Therapeutics
APLT
$25K ﹤0.01%
1,179
– –
AVNW icon
2598
Aviat Networks
AVNW
$287M
$25K ﹤0.01%
+756
New +$26.3K
BIBL icon
2599
Inspire 100 ETF
BIBL
$502M
$25K ﹤0.01%
591
+86
+17% +$3.55K
CARE icon
2600
Carter Bankshares
CARE
$756M
$25K ﹤0.01%
1,998
– –
102 103
104
105 106

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
EPIM
Evelyn Partners Investment Management London $3.68B AUM 21.15% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.